|
Question for the experts
|
1
|
Zenith Epigenetics
|
Oct 08, 2024 12:32PM
|
|
Question for posters
|
13
|
Resverlogix Corp.
|
Dec 09, 2021 12:13PM
|
|
Question
|
4
|
Resverlogix Corp.
|
Feb 23, 2021 01:37PM
|
|
Qatar Research overview of apabetalone
|
4
|
Resverlogix Corp.
|
Apr 23, 2024 08:38PM
|
|
Qatar Research overview of apabetalone
|
1
|
Resverlogix Corp.
|
Apr 23, 2024 08:41PM
|
|
Qatar Research overview of apabetalone
|
3
|
Resverlogix Corp.
|
Apr 23, 2024 08:41PM
|
|
Prostate Cancer News Today Article
|
4
|
Zenith Epigenetics
|
Jul 03, 2019 01:07PM
|
|
Progress
|
5
|
Resverlogix Corp.
|
Dec 08, 2021 11:42AM
|
|
Presentation
|
7
|
Resverlogix Corp.
|
Oct 04, 2021 05:03PM
|
|
Potential
|
5
|
Zenith Epigenetics
|
Jul 17, 2021 09:54AM
|
|
post by F6 at IV re inflammation
|
1
|
Resverlogix Corp.
|
Sep 02, 2017 01:57PM
|
|
Pfizer enzalutimide perspective
|
5
|
Zenith Epigenetics
|
May 14, 2017 02:55PM
|
|
Ownership Update
|
10
|
Resverlogix Corp.
|
Feb 19, 2023 08:14PM
|
|
OTC Trading questions
|
1
|
Zenith Epigenetics
|
Mar 01, 2022 01:02PM
|
|
Orphan Trial Thought
|
1
|
Resverlogix Corp.
|
Jun 28, 2015 09:51AM
|
|
Of interest during this pending financing period
|
2
|
Resverlogix Corp.
|
Mar 07, 2018 04:31PM
|
|
No word on...
|
3
|
Resverlogix Corp.
|
Jul 12, 2021 10:22AM
|
|
Next Hurdle
|
2
|
Resverlogix Corp.
|
Jan 05, 2018 11:12AM
|
|
Nature Briefing article
|
5
|
Resverlogix Corp.
|
Feb 18, 2022 10:16AM
|
|
My Rant - Limited attendance AGM, one way communication, vetted questions
|
2
|
Resverlogix Corp.
|
Jun 20, 2022 08:08PM
|
